Correlation Between OncoVista Innovative and Akeso,

Can any of the company-specific risk be diversified away by investing in both OncoVista Innovative and Akeso, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OncoVista Innovative and Akeso, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between OncoVista Innovative Therapies and Akeso, Inc, you can compare the effects of market volatilities on OncoVista Innovative and Akeso, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OncoVista Innovative with a short position of Akeso,. Check out your portfolio center. Please also check ongoing floating volatility patterns of OncoVista Innovative and Akeso,.

Diversification Opportunities for OncoVista Innovative and Akeso,

-0.51

Correlation Coefficient

OncoVista Innovative  Akeso,

Excellent diversification

The 3 months correlation between OncoVista and Akeso, is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding OncoVista Innovative Therapies and Akeso, Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akeso, Inc and OncoVista Innovative is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OncoVista Innovative Therapies are associated (or correlated) with Akeso,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akeso, Inc has no effect on the direction of OncoVista Innovative i.e., OncoVista Innovative and Akeso, go up and down completely randomly.

Pair Corralation between OncoVista Innovative and Akeso,

Given the investment horizon of 90 days OncoVista Innovative Therapies is expected to under-perform the Akeso,. In addition to that, OncoVista Innovative is 1.56 times more volatile than Akeso, Inc. It trades about -0.12 of its total potential returns per unit of risk. Akeso, Inc is currently generating about 0.12 per unit of volatility. If you would invest  700.00  in Akeso, Inc on December 30, 2024 and sell it today you would earn a total of  200.00  from holding Akeso, Inc or generate 28.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

OncoVista Innovative Therapies  vs.  Akeso, Inc

OncoVista Innovative

Risk-Adjusted Performance

Very Weak

Over the last 90 days OncoVista Innovative Therapies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Akeso, Inc

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Akeso, Inc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Akeso, reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with OncoVista Innovative and Akeso,

The main advantage of trading using opposite OncoVista Innovative and Akeso, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OncoVista Innovative position performs unexpectedly, Akeso, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akeso, will offset losses from the drop in Akeso,'s long position.

The idea behind OncoVista Innovative Therapies and Akeso, Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.